Clinical Trial Update: Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating gabapentin to reduce postoperative delirium and pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Delirium
• Postoperative Pain

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Postoperative Delirium, Postoperative Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-09-10